Cargando…

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes

The authors discuss the strategy of use of incretin hormones in type 2 diabetes treatment in the context of cardiovascular complications. The results of the phase III study on human GLP-1 (Glucagon-like peptide-1) analogue-liraglutide have been presented under common acronym LEAD (Liraglutide-Effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinalska, Ida, Bednarska-Chabowska, Dorota, Adamiec-Mroczek, Joanna, Hak, Łukasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302114/ https://www.ncbi.nlm.nih.gov/pubmed/22462016 http://dx.doi.org/10.5402/2012/625809

Ejemplares similares

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005)

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
por: Hansen, Katrine B, et al.
Publicado: (2010)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

Understanding the Cardiovascular Effects of Incretin
por: Yoon, Ji Sung, et al.
Publicado: (2011)

Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
por: Barbarawi, Mahmoud, et al.
Publicado: (2018)

Small-fibre Neuropathy in Patients with Type 2 Diabetes Mellitus and its Relationship with Diabetic Itch: Preliminary Results
por: STEFANIAK, Aleksandra A., et al.
Publicado: (2022)

GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics
por: Wright, Shane C., et al.
Publicado: (2023)

How should we think about the unprecedented weight loss efficacy of incretin-mimetic drugs?
por: Gou, Yang, et al.
Publicado: (2023)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
por: Ansar, Sameer, et al.
Publicado: (2011)

Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
por: Bader, Miaad, et al.
Publicado: (2020)

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
por: Bonde, Lawrence, et al.
Publicado: (2006)

Itch in Adult Population with Type 2 Diabetes Mellitus: Clinical Profile, Pathogenesis and Disease-Related Burden in a Cross-Sectional Study
por: Stefaniak, Aleksandra A., et al.
Publicado: (2021)

Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
por: Rosenberg, Jared, et al.
Publicado: (2021)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
por: Bernardini, Federico, et al.
Publicado: (2023)

Prevalence of Incretin-Mimetic and Sodium-Glucose-Transporter-2-Inhibitor Therapy in German Hospitalized Type-2 Diabetics Following Myocardial Revascularization: An Observational Study
por: Pliquett, Rainer U., et al.
Publicado: (2020)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Targeting Cardiovascular Risk Factors Through Dietary Adaptations and Caloric Restriction Mimetics
por: Voglhuber, Julia, et al.
Publicado: (2021)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

The cardiovascular safety of incretin-based therapies: a review of the evidence
por: Petrie, John R
Publicado: (2013)

Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
por: Cho, Young Min
Publicado: (2015)

Insulin Secretion and Incretin Hormone Concentration in Women with Previous Gestational Diabetes Mellitus
por: Yu, Sung Hoon, et al.
Publicado: (2011)

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
por: Drucker, Daniel J., et al.
Publicado: (2010)

Cardiovascular safety trials of incretin‐based drugs: What do they mean?
por: Yabe, Daisuke, et al.
Publicado: (2016)

Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies
por: Pan, Qi, et al.
Publicado: (2022)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
por: Mima, Akira
Publicado: (2016)

Incretin Learning and Excellence Academy for Diabetes (iLEAD)
por: Bajaj, Sarita, et al.
Publicado: (2016)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes
por: Zhang, Zeqing, et al.
Publicado: (2017)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2016)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
por: Salehi, Marzieh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ihtq4sgfgi561fh49guhabe6e6